Drug intelligence / Profile preview

pcDNA3.1-EN2

Development stage
Preclinical
Modality
Gene Therapies
Administration
In Vitro
01

Overview

pcDNA3.1-EN2 is a recombinant DNA plasmid vector designed for the overexpression of the Engrailed Homeobox 2 (EN2) protein in mammalian cells. In the context of oncology research, particularly non-small cell lung cancer (NSCLC), this construct is utilized to investigate the tumor-suppressive role of EN2. Overexpression of EN2 via this plasmid has been shown to inhibit the proliferation, migration, and invasion of lung cancer cells, such as the A549 cell line. Mechanistically, the construct works by regulating the G1/S phase transition and suppressing the expression and nuclear translocation of β-catenin, thereby modulating the Wnt/β-catenin signaling pathway.

Other names
EN2-overexpressing plasmidEN-2-overexpressing plasmidEN 2-overexpressing plasmidpcDNA3.1-Engrailed homeobox 2pcDNA-3.1-Engrailed homeobox 2pcDNA 3.1-Engrailed homeobox 2
02

Targets

CTNNB1 (Beta-catenin)EN2 (Engrailed homeobox protein 2)

Beyond the preview

Go deeper on pcDNA3.1-EN2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pcDNA3.1-EN2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call